Search research articles
Contact Us
Filters
Showing results (261-270 of 374) with videos related to
Page
of 38
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
June 8, 2012
Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors
Carissa M White, Whitney B Pope, Taryar Zaw, et al.
Tomography (Ann Arbor, Mich.)
|
January 8, 2016
Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
Warren Chang, Whitney B Pope, Robert J Harris, et al.
Msystems
|
December 23, 2025
Metagenomic analysis of fecal microbiomes reveals genetic potential for diverse hydrogen management strategies in marsupials
Kate L Bowerman, Yang Lu, Harley McRae, et al.
Applied and Environmental Microbiology
|
October 19, 2014
A polysaccharide utilization locus from an uncultured bacteroidetes phylotype suggests ecological adaptation and substrate versatility
A K Mackenzie, A E Naas, S K Kracun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2014
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy
Johannes Schwarzenberg, Johannes Czernin, Timothy F Cloughesy, et al.
AJNR. American Journal of Neuroradiology
|
September 6, 2024
"Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging
Francesco Sanvito, Jingwen Yao, Nicholas S Cho, et al.
Cancer
|
March 22, 2016
Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma
Benjamin M Ellingson, Huytram N Nguyen, Albert Lai, et al.
AJNR. American Journal of Neuroradiology
|
October 19, 2013
Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma
B M Ellingson, S Sahebjam, H J Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2011
3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab
Johannes Schwarzenberg, Johannes Czernin, Timothy F Cloughesy, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
January 23, 2015
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab
Kevin Leu, Dieter R Enzmann, Davis C Woodworth, et al.
Page
of 38
Search research articles
Search
Showing results (261-270 of 374) with videos related to
Sort By:
Page
of 38
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
June 8, 2012
Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors
Carissa M White, Whitney B Pope, Taryar Zaw, et al.
Tomography (Ann Arbor, Mich.)
|
January 8, 2016
Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
Warren Chang, Whitney B Pope, Robert J Harris, et al.
Msystems
|
December 23, 2025
Metagenomic analysis of fecal microbiomes reveals genetic potential for diverse hydrogen management strategies in marsupials
Kate L Bowerman, Yang Lu, Harley McRae, et al.
Applied and Environmental Microbiology
|
October 19, 2014
A polysaccharide utilization locus from an uncultured bacteroidetes phylotype suggests ecological adaptation and substrate versatility
A K Mackenzie, A E Naas, S K Kracun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2014
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy
Johannes Schwarzenberg, Johannes Czernin, Timothy F Cloughesy, et al.
AJNR. American Journal of Neuroradiology
|
September 6, 2024
"Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging
Francesco Sanvito, Jingwen Yao, Nicholas S Cho, et al.
Cancer
|
March 22, 2016
Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma
Benjamin M Ellingson, Huytram N Nguyen, Albert Lai, et al.
AJNR. American Journal of Neuroradiology
|
October 19, 2013
Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma
B M Ellingson, S Sahebjam, H J Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2011
3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab
Johannes Schwarzenberg, Johannes Czernin, Timothy F Cloughesy, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
January 23, 2015
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab
Kevin Leu, Dieter R Enzmann, Davis C Woodworth, et al.
Page
of 38